Abstracts

DVCon U.S. 2023 Announces Call for Extended Abstracts

GAINESVILLE, Fla., May 24, 2022 (GLOBE NEWSWIRE) -- The 2023 Design and Verification Conference and Exhibition United States (DVCon U.S.), sponsored by Accellera Systems Initiative, announces its call ... read more

Amolyt Pharma Announces Abstracts Accepted for Presentation at ECE and ENDO

May 16, 2022 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced that the company has had ... read more

Genmab Announces Multiple Abstracts to Be Presented at the European Hematology Association (EHA) Annual Congress

Genmab A/S (Nasdaq: GMAB) announced today that multiple abstracts evaluating epcoritamab (DuoBody-CD3xCD20), an investigational subcutaneous bispecific antibody, will be presented at the European ... read more

ADC Therapeutics Announces Abstracts to be Presented at the European Hematology Association 2022 Hybrid Congress

ADC Therapeutics SA (NYSE: ADCT), announced today that results from the pivotal Phase 2 clinical trial of camidanlumab tesirine (Cami) in patients with relapsed or refractory Hodgkin lymphoma have ... read more

Biomea Fusion Announces Acceptance of Multiple Abstracts at the 2022 ASCO Annual Meeting

The 2022 ASCO annual meeting will be held from June 3-7, 2022, at McCormick Place in Chicago, IL. The titles of Biomea’s accepted abstracts are listed below. Biomea will disclose additional ... read more

Cecilia Ulibarri's Abstracts Displayed at Nashua Public Library

Cecilia Ulibarri's mixed-media art exhibit entitled "Journeys of an Artist," will be on display at Nashua Public Library until June 30 ... read more

AskBio to Present 11 Abstracts at Upcoming American Society of Gene and Cell Therapy's 25th Annual Meeting

RESEARCH TRIANGLE PARK, N.C., May 16, 2022 /PRNewswire/ -- Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, today announced that the ... read more

Curis Announces Abstracts Accepted for Presentation at the European Hematology Association 2022 Congress (EHA)

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that multiple abstracts have been accepted for ... read more

Travere Therapeutics Announces Presentations of Abstracts at the 59th ERA Congress

Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced presentations including baseline characteristics for patients enrolled in the ongoing pivotal Phase 3 PROTECT and DUPLEX studies of sparsentan ... read more

Iterative Scopes to Present Three Abstracts on Artificial Intelligence Applications for GI Endoscopy at DDW 2022

The meeting showcases more than 5,000 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology. More information can be found at www.ddw.org . read more